Abhinav Kalra

DDS | Dentist



  
  1811 Highway 287 N Ste 160, Mansfield
  Texas, 76063-7571

  817-453-1001    817-453-1221 Maps & Directions
Abhinav Kalra is a Mansfield, Texas based Dentist who is specialized in Dentistry. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 1811 Highway 287 N Ste 160, Mansfield. Patients can reach him at 817-453-1001.
Abhinav Kalra is the primary dental care provider for patients of all ages. He is responsible for the diagnosis, treatment, management and overall coordination of services related to patients' oral health needs.
Complete Profile:
Abhinav Kalra speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Abhinav Kalra
Specialization: Dentist
Gender:Male
Credentials: DDS
Accepts Medicare Assignment:May Accept
Practice Address:1811 Highway 287 N Ste 160, Mansfield,
Texas, 76063-7571
Phone:817-453-1001
Fax:817-453-1221
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 1658665047
Enrollment ID: I20160808001907
NPI Number: 1023561933
NPI Enumeration Date: 27 Jul, 2016
NPI Last Update On: 07 Jul, 2022

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 1811 Highway 287 N Ste 160,
Mansfield, Texas
Zip: 76063-7571
Phone Number: 817-453-1001
Fax Number: 817-453-1221
Patients can reach Abhinav Kalra at 1811 Highway 287 N Ste 160, Mansfield, Texas or can call to book an appointment on 817-453-1001. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.

Comments/ Reviews: